DNA sequence variants of the FKBP5 gene are associated with unipolar depression

International Journal of Neuropsychopharmacology

Volumn 13, Issue 5, 2010, Pages 649-660

  Zobel, Astrid ^a   Schuhmacher, Anna ^a   Jessen, Frank ^a   Hfels, Susanne ^a   Von Widdern, Olrik ^a   Metten, Martin ^a   Pfeiffer, Ute ^a   Hanses, Claudia ^a   Becker, Tim ^a   Rietschel, Marcella ^a,b   Scheef, Lukas ^a   Block, Wolfgang ^a   Schild, Hans H ^a   Maier, Wolfgang ^a   Schwab, Sibylle G ^a,c  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Depression related phenotypes; FKBP5; Hippocampus; HPA; Unipolar depression

Indexed keywords

CITALOPRAM; FKBP5 PROTEIN; HEAT SHOCK PROTEIN 90; IMMUNOPHILIN; LORAZEPAM; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORTICOTROPIN RELEASE; DNA SEQUENCE; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAMILTON SCALE; HIPPOCAMPUS; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; CITALOPRAM; DEPRESSIVE DISORDER; FEMALE; GENETIC LINKAGE; GENETIC MARKERS; GENETIC VARIATION; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TACROLIMUS BINDING PROTEINS; YOUNG ADULT;

EID: 77953544577     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145709991155     Document Type: Article

References (28)

1. Balu DT, Lucki I (2009). Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology. Neuroscience Biobehavioral Reviews 33, 232-252.
2. Becker T, Cichon S, Jonson E, Knapp M (2005). Multiple testing in the context of haplotype analysis revisited: application to case-control data. Annals of Human Genetics 69, 747-756.
3. Becker T, Knapp M (2004). Maximum-likelihood estimation of haplotype frequencies in nuclear families. Genetic Epidemiology 27, 21-32.
4. Binder EB, Bradley RG, Liu W, Epstein MP, et al. (2008). Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. Journal of the American Medical Association 299, 1291-1305.
5. Binder EB, Salyakina D, Lichtner P, Wochnik GM, et al. (2004). Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nature Genetics 36, 1319-1325.
6. Frodl T, Moller HJ, Meisenzahl E (2008). Neuroimaging genetics: new perspectives in research on major depression? Acta Psychiatrica Scandinavica 118, 363-372.
7. Gawlik M, Moller-Ehrlich K, Mende M, Jovnerovski M, et al. (2006). Is FKBP5 a genetic marker of affective psychosis? A case control study and analysis of disease related traits. BMC Psychiatry 6, 52. Hamilton M (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23, 56-62.
8. Heuser I, Schweiger U, Gotthardt U, Schmider J, et al. (1996). Pituitary-adrenal-system regulation and psychopathology during amitryptiline treatment in elderly depressed patients and normal comparison subjects. American Journal of Psychiatry 153, 93-99.
9. Heuser I, Yassouridis A, Holsboer F (1994). The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. Journal of Psychiatric Research 28, 341-356.
10. Holsboer-Trachsler E, Stohler R, Hatzinger M (1991). Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression. Psychiatry Research 38, 163-171.
11. Ising M, Depping AM, Siebertz A, Lucae S, et al. (2008). Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls. European Journal of Neuroscience 28, 389-398.
12. Ising M, Horstmann S, Kloiber S, Lucae S, et al. (2007). Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression-a potential biomarker? Biological Psychiatry 62, 47-54.
13. Kirchheiner J, Lorch R, Lebedeva E, Seeringer A, et al. (2008). Genetic variants in FKBP5 affecting response to antidepressant drug treatment. Pharmacogenomics 9, 841-846.
14. Lekman M, Laje G, Charney D, Rush AJ, et al. (2008). The FKBP5-gene in depression and treatment response-an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort. Biological Psychiatry 63, 1103-1110.
15. McKinnon MC, Yucel K, Nazarov A, MacQueen GM (2009). A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. Journal of Psychiatry & Neuroscience 34, 41-54.
16. Nyholt DR (2004). A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. American Journal of Human Genetics 74, 765-769.
17. Papiol S, Arias B, Gasto C, Gutierrez B, et al. (2007). Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment. Journal of Affective Disorders 104, 83-90.
18. Park J, Kim M, Na G, Jeon I, et al. (2007). Glucocorticoids modulate NF-kappaB-dependent gene expression by up-regulating FKBP51 expression in Newcastle disease virus-infected chickens. Molecular and Cellular Endocrinology 278, 7-17.
19. Purcell S, Cherny SS, Sham PC (2003). Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19, 149-150.
20. Salyakina D, Seaman SR, Browning BL, Dudbridge F, et al. (2005). Evaluation of Nyholt's procedure for multiple testing correction. Human Heredity 60, 19-25.
21. Savitz J, Drevets WC (2009). Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neuroscience and Biobehavioral Reviews 33, 699-771.
22. Schwab SG, Franke PE, Hoefgen B, Guttenthaler V, et al. (2005). Association of DNA polymorphisms in the synaptic vesicular amine transporter gene (SLC18A2) with alcohol and nicotine dependence. Neuropsychopharmacology 30, 2263-2268.
23. Tsai SJ, Hong CJ, Chen TJ, Yu YW (2007). Lack of supporting evidence for a genetic association of the FKBP5 polymorphism and response to antidepressant treatment. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 144, 1097-1098.
24. Willour VL, Chen H, Toolan J, Belmonte P, et al. (2009). Family-based association of FKBP5 in bipolar disorder. Molecular Psychiatry 14, 261-268.
25. Wittchen HU, Zaudig M, Fydrich T (1997). Strukturiertes Klinisches Interview für DSM-IV (SKID-I und SKID-II) Achse I: psychische Störungen/Achse II: Persönlichkeitsstörungen. Göttingen, Bern, Toronto, Seattle: Hogrefe Verlag für Psychologie.
26. Zobel A, Maier W (2004). Endophenotypes: a new concept for the biological characterization of mental disorders. Nervenarzt 75, 205-214.
27. Zobel A, Maier W (2009). Pharmacogenetics of antidepressive treatment. European Archives of Psychiatry and Clinical Science. doi:10.1007/s00406-009- 0091-4.
28. Zobel AW, Nickel T, Sonntag A, Uhr M, et al. (2001). Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression: a prospective study. Journal of Psychiatric Research 35, 83-94.